Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Good

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Antiviral Research|March 7, 2025
Bemnifosbuvir and ruzasvir in combination exhibit potent synergistic antiviral activity in vitro while maintaining a favorable nonclinical safety profile in vivoSteven S Good, Shouqi Luo, Kai Lin, et al.
Journal of the Neurological Sciences|December 1, 1987
Childhood giant axonal neuropathy. Case report and review of the literatureR Tandan, B W Little, E S Emery, et al.
Postgraduate Medical Journal|December 1, 1970
A comparative study of glibenclamide and chlorpropamide. (Preliminary report)J J Hamblin, G Ismay, M S Good, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1990
Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humansS S Good, C S Koble, R Crouch, et al.
Cancer Research|October 1, 1993
In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminaseB E Huber, E A Austin, S S Good, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|June 30, 2012
CathAway fistula vascular access program achieves improved outcomes and sets a new standard of treatment for end-stage renal diseaseSteven M Wilson, Tracy J Mayne, Mahesh Krishnan, et al.
Journal of Glaucoma|January 17, 2007
The risk of glaucoma in pseudoexfoliation syndromeSamuel M Jeng, Randy A Karger, David O Hodge, et al.
Expert Opinion on Investigational Drugs|January 24, 2024
Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymeraseXiao-Jian Zhou, Steven S Good, Keith Pietropaolo, et al.
Journal of General Internal Medicine|May 31, 2014
Provider and patient expectations for dietary supplement discussionsDerjung M Tarn, Jennifer R Guzmán, Jeffrey S Good, et al.
Clinical Pharmacology and Therapeutics|November 1, 1981
Disposition of intravenous radioactive acyclovirP de Miranda, S S Good, O L Laskin, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Antiviral Research|March 7, 2025
Bemnifosbuvir and ruzasvir in combination exhibit potent synergistic antiviral activity in vitro while maintaining a favorable nonclinical safety profile in vivoSteven S Good, Shouqi Luo, Kai Lin, et al.
Journal of the Neurological Sciences|December 1, 1987
Childhood giant axonal neuropathy. Case report and review of the literatureR Tandan, B W Little, E S Emery, et al.
Postgraduate Medical Journal|December 1, 1970
A comparative study of glibenclamide and chlorpropamide. (Preliminary report)J J Hamblin, G Ismay, M S Good, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1990
Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humansS S Good, C S Koble, R Crouch, et al.
Cancer Research|October 1, 1993
In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminaseB E Huber, E A Austin, S S Good, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|June 30, 2012
CathAway fistula vascular access program achieves improved outcomes and sets a new standard of treatment for end-stage renal diseaseSteven M Wilson, Tracy J Mayne, Mahesh Krishnan, et al.
Journal of Glaucoma|January 17, 2007
The risk of glaucoma in pseudoexfoliation syndromeSamuel M Jeng, Randy A Karger, David O Hodge, et al.
Expert Opinion on Investigational Drugs|January 24, 2024
Bemnifosbuvir (BEM, AT-527), a novel nucleotide analogue inhibitor of the hepatitis C virus NS5B polymeraseXiao-Jian Zhou, Steven S Good, Keith Pietropaolo, et al.
Journal of General Internal Medicine|May 31, 2014
Provider and patient expectations for dietary supplement discussionsDerjung M Tarn, Jennifer R Guzmán, Jeffrey S Good, et al.
Clinical Pharmacology and Therapeutics|November 1, 1981
Disposition of intravenous radioactive acyclovirP de Miranda, S S Good, O L Laskin, et al.
Pageof 11